This study documents hemato-biochemical analysis and treatment response to enrofloxacin in five domestic cats affected with FHM. Diagnosis of FHM was arrived after detecting H. felis on DiffQuick stained peripheral blood smear. All the cats underwent hemato-biochemical analysis pre- (day 0) and post treatment (day 15). Mean values of WBC, RBCs, HCT, MCV, MCHC, MCH, AST, ALT and total bilirubin at day 0 were found to be 20.6 x 109 /L, 3.53 x 1012/L, 21.6%, 46.3 fL, 34.2 G/dL, 19.4 pg, 238 U/L, 219 U/L and 2.38 mg/dL, respectively. Similarly, mean values of WBC, RBCs, HCT, MCV, MCHC, MCH, AST, ALT and total bilirubin at day 15 were found to be 10.8x109 /L, 6.56 x 1012/L, 38.2%, 50.9 fL, 33.1 G/dL, 14.2 pg, 35.2 U/L, 39.8 U/L and 0.35 mg/dL, respectively. Additionally, a slightly elevated WBC count (all cats) with mild basophilia (8% in cat 4) and monocytosis (11.3% in cat 4) was also appreciated. All the affected cats were treated successfully using a combination of enrofloxacin (10mg/kg, IM) and prednisolone (1mg/kg B.wt, IM) for 21 days. The goal of present study was to assess the clinical cases of FHM diagnosed in Pakistan, with a view to ascertain the hemato-biochemical findings, clinical signs and response to treatment.